endpts.com Open in urlscan Pro
108.138.36.63  Public Scan

Form analysis
1 forms found in the DOM

https://endpts.com/

<form action="https://endpts.com/">
  <input type="text" name="s" placeholder="Search">
  <button class="epn_ux_button epn_white epn_search_submit_button"></button>
</form>

Text Content

 * Channels
   * All News
   * In Focus
   * Special
   * AI
   * Bioregnum
   * Biotech Voices
   * Cell/Gene Tx
   * China
   * Coronavirus
   * Deals
   * Diagnostics
   * Discovery
   * FDA+
   * Financing
   * Health Tech
   * Law
   * Letters to the Editor
   * Manufacturing
   * Marketing
   * Opinion
   * Outsourcing
   * Peer Review
   * People
   * Pharma
   * R&D
   * Startups
   * Weekly
 * Webinars
 * Biopharma Jobs
 * More
   * Work at Endpoints
   * Letter to Editors
   * Editorial Standards
   * IPO Tracker
   * Webinars
   * Events
   * Sponsored Posts
   * Advertise
   * Privacy Policy
   * Endpoints Merch
   * About Us
   * Help


 * SIGN UP
 * LOG IN



November 13, 2023 04:41 PM ESTUpdated November 14, 05:58 AM
People
Startups


OR­BITAL THER­A­PEU­TICS CLOS­ES SOUTH SAN FRAN­CIS­CO LAB, ELIM­I­NAT­ING SOME
ROLES


KYLE LAHUCIK

SENIOR REPORTER

Or­bital Ther­a­peu­tics, a well-fund­ed biotech born out of buzzy base edit­ing
com­pa­ny Beam Ther­a­peu­tics, has shut­tered its South San Fran­cis­co
of­fice.

The start­up was un­veiled in April with a $270 mil­lion Se­ries A from ARCH
Ven­ture Part­ners, a16z Bio + Health, and more than half a dozen oth­er
in­vestors. The com­pa­ny is work­ing on RNA med­i­cines in­clud­ing vac­cines,
pro­tein re­place­ment ther­a­pies and im­munomod­u­la­tors, with the first
ex­pect­ed to en­ter the clin­ic with­in two to four years, CEO Giuseppe
Cia­ramel­la told End­points News at the time.


UNLOCK THIS ARTICLE INSTANTLY BY BECOMING A FREE SUBSCRIBER.

You’ll get access to free articles each month, plus you can customize what
newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER


TRENDING NOW


FDA AP­PROVES VER­TEX AND CRISPR'S CAS­GEVY AS FIRST CRISPR-EDIT­ED THER­A­PY
FOR BE­TA-THA­LASSEMIA


HOW PHAR­MA GI­ANTS LIKE GSK AND BRIS­TOL MY­ERS ARE US­ING TECH TO SHAPE THEIR
FU­TURE


NO­VO NORDISK RESTARTS AD­VER­TIS­ING FOR OBE­SI­TY DRUG WE­GOVY WITH NEW
CAM­PAIGN


AM­I­CUS BRIEFS FLY IN AS IRA 'FAIR PRICE' DEAD­LINE LOOMS


A DECADE AF­TER ITS FIRST FDA AP­PROVAL, TAKE­DA EX­PANDS LA­BEL OF HYQVIA TO
IN­CLUDE RARE AU­TOIM­MUNE DIS­OR­DER

sponsored


BIOTECH: A NEW PATH TO CAP­I­TAL RAIS­ING IN PUB­LIC AND PRI­VATE MAR­KETS

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas




LATEST

 * All News
 * Special
 * In Focus
   


CHANNELS

 * AI
 * Bioregnum
 * Biotech Voices
 * Cell/Gene Tx
 * China
 * Coronavirus
 * Deals
 * Diagnostics
 * Discovery
 * FDA+
 * Financing
 * Health Tech
 * Law
 * Letters to the Editor
 * Manufacturing
 * Marketing
 * Opinion
 * Outsourcing
 * Peer Review
 * People
 * Pharma
 * R&D
 * Startups
 * Weekly


MORE

 * Work at Endpoints
 * Letter to Editors
 * Editorial Standards
 * IPO Tracker
 * Events
 * Webinars
 * Sponsored Posts
 * Advertise
 * Endpoints Merch
 * About Us
 * Help


WORK IN BIOTECH

 * Endpoints Careers

© Endpoints News 2024

 * Help
 * Advertise
 * Privacy Policy
 * Business Model




LOG IN TO YOUR ACCOUNT


EMAIL




PASSWORD


Change my password Get a magic email link
LOG IN


REQUEST MAGIC LINK

If you're already an Endpoints subscriber, enter your email below for a magic
link that lets you log in quickly without using a password. Please note the
magic link is one-time use only and expires after 24 hours.


EMAIL


BACK
REQUEST


RESET PASSWORD

We'll e-mail you a link to set a new password. Please note this link is one-time
use only and is valid for only 24 hours.


EMAIL


BACK
RESET

SIGN UP FOR FREE TO READ A LIMITED NUMBER OF ARTICLES EACH MONTH.

ABOUT YOU







NEWSLETTER INTERESTS

PICK WHAT NEWSLETTERS GET DELIVERED TO YOUR INBOX EACH WEEK.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET



EARLY EDITION Daily at 7:15 AM ET



ENDPOINTS PHARMA Daily at 2 PM ET



BREAKING NEWS ALERTS 2-3 times a week



ENDPOINTS MARKETING RX Tue at 2 PM ET



ENDPOINTS FDA+ Wed at 2 PM ET



ENDPOINTS MANUFACTURING Thu at 2 PM ET



ENDPOINTS WEEKLY Sat at 6 AM ET



Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET



BREAKING NEWS ALERTS 2-3 times a week


INSTANT SIGN UP

Want unlimited access? Sign up for a premium subscription plan.